您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Terin D'Amico1, Michael A Serwetnyk1, Xiaozheng Dou1
1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, 46556, USA.
开发针对热冲击蛋白90β (Hsp90β) 的异形选择性抑制剂提供了一个有前途的治疗策略. 这项研究探讨了结构修改以增强Hsp90β亲和力和选择性,克服以前泛抑制剂的局限性.
06:51Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: